Loading stock data…
CI
$282.90-7.68 (-2.64%)
Market ClosedLast close May 1
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Cigna Group in the Healthcare sector is trading at $282.90. The stock is currently 17% below its 52-week high of $338.89, remaining 1.1% above its 200-day moving average. Technical signals show neutral RSI of 57 and bullish MACD crossover, explaining why CI maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 57) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$282.90
Potential Upside
64.8%
Whystock Fair Value$466.32
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus24 analysts
Mean target$339.58+20.0%
Range$290.00 – $378.00
Fundamentals
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$73.38B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.38
Beta
Defensive asset. Lower volatility than the S&P 500.
0.27
Div Yield
Strong income play. Yield provides a meaningful total return floor.
226.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.03%
Volume
Today's trading volume
1.52M
Recent News
The The Cigna Group (NYSE:CI) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Investors in The Cigna Group ( NYSE:CI ) had a good week, as its shares rose 2.6% to close at US$283 following the...
CI Q1 Deep Dive: Specialty Growth, Portfolio Reshaping, and New Pharmacy Model Drive Outlook
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q1 CY2026, with sales up 4.7% year on year to $68.52 billion. Its non-GAAP profit of $7.79 per share was 2.4% above analysts’ consensus estimates.
Cigna Group Q1 Earnings Call Highlights
The Cigna Group (NYSE:CI) reported a strong start to 2026 and raised its full-year adjusted earnings outlook following first-quarter results that management said exceeded expectations in key areas, while also announcing additional portfolio changes and providing an update on its leadership transitio
Cigna Corporation Q1 2026 Earnings Call Summary
Moby summary of Cigna Corporation's Q1 2026 earnings call
Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit
CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.